GSK CEO: Our top priority is to invest in growth in our core pharma business

Emma Walmsley, GlaxoSmithKlein CEO, speaks to CNBC's Meg Tirrell at the J.P. Morgan Health Care Conference about reshaping the company and her outlook for 2018.
03:58
Mon, Jan 8 201811:24 AM EST